{"id":38409,"date":"2017-02-09T00:00:00","date_gmt":"2017-02-08T23:00:00","guid":{"rendered":"http:\/\/www.pcb.ub.edu\/\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\/"},"modified":"2020-11-16T16:19:58","modified_gmt":"2020-11-16T15:19:58","slug":"alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker","status":"publish","type":"post","link":"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\/","title":{"rendered":"Alianza entre SOM Biotech y Duchenne Parent Project Espanya para combatir las distrofias musculares de Duchenne y Becker"},"content":{"rendered":"<p>SOM Biotech, con sede en el Parc Cient\u00edfic de Barcelona, es una de las pocas biofarmac\u00e9uticas del mundo especializada en identificar nuevas actividades terap\u00e9uticas de medicamentos aprobados para otra indicaci\u00f3n (reposicionamento), con especial \u00e9nfasis en enfermedades raras. En virtud de este acuerdo, el equipo de la <em>biotech <\/em>se encargar\u00e1 de la identificaci\u00f3n <em>in silico<\/em> de compuestos activos frente a la Distrofia Muscular de Duchenne (DMD) y Becker (DMB) \u2013mediante tecnolog\u00eda computacional propia\u2013 y de la realizaci\u00f3n de los estudios <em>in vitro <\/em>de los f\u00e1rmacos reposicionados candidatos para confirmar su actividad frente a la\u00a0enfermedad.<\/p>\n<p>Duchenne Parent\u00a0Project Espa\u00f1a (DPPE) es una asociaci\u00f3n sin \u00e1nimo de lucro creada y dirigida por padres de ni\u00f1os con distrofias DMD y DMB. Su colaboraci\u00f3n se centrar\u00e1 en la primera etapa del proyecto, focalizada\u00a0en identificar f\u00e1rmacos reposicionados capaces de ser usados en este tipo de trastornos, y se materializar\u00e1 en una donaci\u00f3n de 25.000\u20ac a SOM\u00a0Biotech.<\/p>\n<p>Seg\u00fan el Dr. Ra\u00fal Insa, CEO de la biofarmac\u00e9utica, \u201cEsta colaboraci\u00f3n pone de relieve la confianza de DPPE en la experiencia de SOM Biotech en el campo del reposicionamento de f\u00e1rmacos para tratar enfermedades minoritarias. Si todo sigue su curso los primeros ensayos cl\u00ednicos pueden ser una realidad en 2018\u201d.<\/p>\n<p>En opini\u00f3n de la Dra. Marisol Montolio, directora cient\u00edfica de Duchenne Parent Project Espa\u00f1a, \u201cApostar por el reposicionamento de f\u00e1rmacos est\u00e1 dentro de nuestra estrategia puesto que se trata de una manera r\u00e1pida de encontrar f\u00e1rmacos de utilidad para las Distrofias Musculares de Duchenne y Becker\u201d.<\/p>\n<p>\n<strong>La distrofia muscular m\u00e1s com\u00fan diagnosticada durante la infancia<\/strong><\/p>\n<p>La Distrofia Muscular de Duchenne (DMD) es la distrofia muscular m\u00e1s com\u00fan diagnosticada durante la infancia y \u00a0afecta a 1 de cada 3.500 ni\u00f1os en el mundo (alrededor de 20.000 nuevos casos cada a\u00f1o), seg\u00fan datos de la asociaci\u00f3n DPPE. \u00a0La enfermedad est\u00e1 ligada a\u00a0mutaciones en el gen que codifica la distrofina. La ausencia de esta prote\u00edna provoca el deterioro progresivo de las fibras musculares y los afectados acaban perdiendo su movilidad.\u00a0Los ni\u00f1os necesitan silla de ruedas alrededor de los 12 a\u00f1os y la expectativa media de vida\u00a0es de 25-30 a\u00f1os.<\/p>\n<p>La Distrofia Muscular de Becker (DMB) es menos grave que la de Duchenne y se produce cuando la distrofina se fabrica, pero no en la forma ni cantidad normal. La diferencia principal es que la evoluci\u00f3n de la enfermedad es mucho m\u00e1s lenta y es menos com\u00fan. Este trastorno aparece en aproximadamente 3 a 6 de cada 100.000 nacimientos.\u00a0<\/p>\n<p>Actualmente no existe cura para estas enfermedades. El objetivo del tratamientos disponibles es controlar los s\u00edntomas para optimizar la calidad de vida de los ni\u00f1os.<\/p>\n<p>\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La biofarmac\u00e9utica <a href=\"http:\/\/www.pcb.ub.edu\/portal\/ca\/cerca?p_p_id=cercador_WAR_empleatsempresesportlet&amp;p_p_lifecycle=0&amp;p_p_state=maximized&amp;p_p_mode=view&amp;p_p_col_id=column-1&amp;p_p_col_count=1&amp;_cercador_WAR_empleatsempresesportlet_jspPage=%2Fhtml%2Fcommon%2Fdetall-empresa.jsp&amp;_cercador_WAR_empleatsempresesportlet_empresaId=ENT_003948&amp;_cercador_WAR_empleatsempresesportlet_redirect=%2Fportal%2Fca%2Fcerca%3Fp_p_id%3Dcercador_WAR_empleatsempresesportlet%26p_p_lifecycle%3D0%26p_p_mode%3Dview%26_cercador_WAR_empleatsempresesportlet_keywords%3DSOM%26_cercador_WAR_empleatsempresesportlet_tab%3D1\" target=\"_blank\" rel=\"noopener noreferrer\">SOM Biotech<\/a> y\u00a0<a href=\"https:\/\/www.duchenne-spain.org\/asociacion\/\" target=\"_blank\" rel=\"noopener noreferrer\">Duchenne Parent Project Espanya <\/a>(DPPE) han firmado un acuerdo de colaboraci\u00f3n para desarrollar un proyecto de reposicionamiento de f\u00e1rmacos para la Distrofia Muscular de Duchenne (DMD) y Becker (DMB), dos trastornos degenerativos e incapacitantes, a menudo mortales,\u00a0y que aparecen durante\u00a0la infancia.\u00a0La<em> biotech<\/em>, con sede en el Parc Cient\u00edfic de Barcelona, se encargar\u00e1 de identificar y ensayar<em> in vitro<\/em>\u00a0f\u00e1rmacos reposicionados\u00a0para tratar estas enfermedades hu\u00e9rfanas, y la asociaci\u00f3n de pacientes DPPE \u2013dirigida por padres de ni\u00f1os con distrofias DMD y DMB\u2013 cofinanciar\u00e1 estos primeros estudios de desarrollo y evaluaci\u00f3n\u00a0precl\u00ednica\u00a0de los compuestos candidatos.<\/p>\n<p>\u00a0<\/p>\n","protected":false},"author":1,"featured_media":24159,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[9],"tags":[],"class_list":["post-38409","post","type-post","status-publish","format-standard","has-post-thumbnail","category-sin-categorizar"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Alianza entre SOM Biotech y Duchenne Parent Project Espanya para combatir las distrofias musculares de Duchenne y Becker - Parc Cient\u00edfic de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alianza entre SOM Biotech y Duchenne Parent Project Espanya para combatir las distrofias musculares de Duchenne y Becker - Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"og:description\" content=\"La biofarmac\u00e9utica SOM Biotech y\u00a0Duchenne Parent Project Espanya (DPPE) han firmado un acuerdo de colaboraci\u00f3n para desarrollar un proyecto de reposicionamiento de f\u00e1rmacos para la Distrofia Muscular de Duchenne (DMD) y Becker (DMB), dos trastornos degenerativos e incapacitantes, a menudo mortales,\u00a0y que aparecen durante\u00a0la infancia.\u00a0La biotech, con sede en el Parc Cient\u00edfic de Barcelona, se encargar\u00e1 de identificar y ensayar in vitro\u00a0f\u00e1rmacos reposicionados\u00a0para tratar estas enfermedades hu\u00e9rfanas, y la asociaci\u00f3n de pacientes DPPE \u2013dirigida por padres de ni\u00f1os con distrofias DMD y DMB\u2013 cofinanciar\u00e1 estos primeros estudios de desarrollo y evaluaci\u00f3n\u00a0precl\u00ednica\u00a0de los compuestos candidatos. \u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\/\" \/>\n<meta property=\"og:site_name\" content=\"Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"article:published_time\" content=\"2017-02-08T23:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-11-16T15:19:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2017\/02\/16049213355fa927f712787.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"437\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"adminpcb\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"adminpcb\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\\\/\"},\"author\":{\"name\":\"adminpcb\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/d13cab05cd0a75b17fddca8496481021\"},\"headline\":\"Alianza entre SOM Biotech y Duchenne Parent Project Espanya para combatir las distrofias musculares de Duchenne y Becker\",\"datePublished\":\"2017-02-08T23:00:00+00:00\",\"dateModified\":\"2020-11-16T15:19:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\\\/\"},\"wordCount\":488,\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2017\\\/02\\\/16049213355fa927f712787.jpeg\",\"articleSection\":[\"Sin categorizar\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\\\/\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\\\/\",\"name\":\"Alianza entre SOM Biotech y Duchenne Parent Project Espanya para combatir las distrofias musculares de Duchenne y Becker - Parc Cient\u00edfic de Barcelona\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2017\\\/02\\\/16049213355fa927f712787.jpeg\",\"datePublished\":\"2017-02-08T23:00:00+00:00\",\"dateModified\":\"2020-11-16T15:19:58+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/d13cab05cd0a75b17fddca8496481021\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2017\\\/02\\\/16049213355fa927f712787.jpeg\",\"contentUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2017\\\/02\\\/16049213355fa927f712787.jpeg\",\"width\":800,\"height\":437},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alianza entre SOM Biotech y Duchenne Parent Project Espanya para combatir las distrofias musculares de Duchenne y Becker\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\",\"name\":\"Parc Cient\u00edfic de Barcelona\",\"description\":\"Universitat de Barcelona\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/d13cab05cd0a75b17fddca8496481021\",\"name\":\"adminpcb\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g\",\"caption\":\"adminpcb\"},\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/author\\\/adminpcb\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alianza entre SOM Biotech y Duchenne Parent Project Espanya para combatir las distrofias musculares de Duchenne y Becker - Parc Cient\u00edfic de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\/","og_locale":"es_ES","og_type":"article","og_title":"Alianza entre SOM Biotech y Duchenne Parent Project Espanya para combatir las distrofias musculares de Duchenne y Becker - Parc Cient\u00edfic de Barcelona","og_description":"La biofarmac\u00e9utica SOM Biotech y\u00a0Duchenne Parent Project Espanya (DPPE) han firmado un acuerdo de colaboraci\u00f3n para desarrollar un proyecto de reposicionamiento de f\u00e1rmacos para la Distrofia Muscular de Duchenne (DMD) y Becker (DMB), dos trastornos degenerativos e incapacitantes, a menudo mortales,\u00a0y que aparecen durante\u00a0la infancia.\u00a0La biotech, con sede en el Parc Cient\u00edfic de Barcelona, se encargar\u00e1 de identificar y ensayar in vitro\u00a0f\u00e1rmacos reposicionados\u00a0para tratar estas enfermedades hu\u00e9rfanas, y la asociaci\u00f3n de pacientes DPPE \u2013dirigida por padres de ni\u00f1os con distrofias DMD y DMB\u2013 cofinanciar\u00e1 estos primeros estudios de desarrollo y evaluaci\u00f3n\u00a0precl\u00ednica\u00a0de los compuestos candidatos. \u00a0","og_url":"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\/","og_site_name":"Parc Cient\u00edfic de Barcelona","article_published_time":"2017-02-08T23:00:00+00:00","article_modified_time":"2020-11-16T15:19:58+00:00","og_image":[{"width":800,"height":437,"url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2017\/02\/16049213355fa927f712787.jpeg","type":"image\/jpeg"}],"author":"adminpcb","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"adminpcb","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\/#article","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\/"},"author":{"name":"adminpcb","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/d13cab05cd0a75b17fddca8496481021"},"headline":"Alianza entre SOM Biotech y Duchenne Parent Project Espanya para combatir las distrofias musculares de Duchenne y Becker","datePublished":"2017-02-08T23:00:00+00:00","dateModified":"2020-11-16T15:19:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\/"},"wordCount":488,"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2017\/02\/16049213355fa927f712787.jpeg","articleSection":["Sin categorizar"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\/","url":"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\/","name":"Alianza entre SOM Biotech y Duchenne Parent Project Espanya para combatir las distrofias musculares de Duchenne y Becker - Parc Cient\u00edfic de Barcelona","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\/#primaryimage"},"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2017\/02\/16049213355fa927f712787.jpeg","datePublished":"2017-02-08T23:00:00+00:00","dateModified":"2020-11-16T15:19:58+00:00","author":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/d13cab05cd0a75b17fddca8496481021"},"breadcrumb":{"@id":"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pcb.ub.edu\/es\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\/#primaryimage","url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2017\/02\/16049213355fa927f712787.jpeg","contentUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2017\/02\/16049213355fa927f712787.jpeg","width":800,"height":437},{"@type":"BreadcrumbList","@id":"https:\/\/www.pcb.ub.edu\/es\/alianza-entre-som-biotech-y-duchenne-parent-project-espanya-para-combatir-las-distrofias-musculares-de-duchenne-y-becker\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pcb.ub.edu\/es\/"},{"@type":"ListItem","position":2,"name":"Alianza entre SOM Biotech y Duchenne Parent Project Espanya para combatir las distrofias musculares de Duchenne y Becker"}]},{"@type":"WebSite","@id":"https:\/\/www.pcb.ub.edu\/es\/#website","url":"https:\/\/www.pcb.ub.edu\/es\/","name":"Parc Cient\u00edfic de Barcelona","description":"Universitat de Barcelona","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pcb.ub.edu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/d13cab05cd0a75b17fddca8496481021","name":"adminpcb","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g","caption":"adminpcb"},"url":"https:\/\/www.pcb.ub.edu\/es\/author\/adminpcb\/"}]}},"_links":{"self":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/38409","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/comments?post=38409"}],"version-history":[{"count":1,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/38409\/revisions"}],"predecessor-version":[{"id":44543,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/38409\/revisions\/44543"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media\/24159"}],"wp:attachment":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media?parent=38409"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/categories?post=38409"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/tags?post=38409"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}